Binnopharm Group has placed exchange bonds of 4 billion rubles

Leading pharmaceutical company Binnopharm Group has placed exchange bonds of series 001P-04. The flotation value amounted to 4 billion rubles subject to the rate of 25.5%. The nominal value of one security of the issue is 1,000 rubles. The maturity period is 3 years with the provided offer after 1.5 years, as well as a monthly coupon payment.

Khafiz Gafurov, Chief Financial Officer of Binnopharm Group: «The company has been represented on the Russian corporate bond market since 2021. Binnopharm Group credit rating has remained at the ruA level with the stable outlook for several years. The third issue of bonds was assigned a similar rating.

A significant oversubscription for a new placement demonstrates the investors’ confidence in the company’s plans aimed at optimisation of the working capital and adjustment of the operations to the Central Bank’s more stringent monetary policy».

The organisers of the placement included VTB Capital Trading, Sinara Investment Bank, IFC Solid, MKB, Sber CIB, Sovcombank, and T-Bank. The issue is placed within the framework of the exchange bond programme series 001P in the amount of 50 billion rubles inclusive or the equivalent of this amount in foreign currency.